To gain insight into the molecular mechanisms that accelerate diabetes development upon NF-κB inhibition in our MODY4 model, we performed microarray-based gene expression analyses using isolated islets of early and progressed disease phases. The gene discussed is NFKB1; the disease is diabetes mellitus.